Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Management of Parkinson’s Disease in the 21st Century—Lessons Learned and How to Move On"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 20 July 2023 | Viewed by 2213
Special Issue Editors
Interests: neurology; neurodegeneration; movement disorders; Parkinson’s disease; neuroinflammation
2. Department of Neurology, Xuzhou Medical University, Xuzhou, China
Interests: neuroscience; obesity
Special Issue Information
Parkinson’s disease is a common neurodegenerative disorder which involves the loss of nigral dopaminergic neurons. There are no proven neuroprotective treatments for Parkinson’s disease, but drugs are effective in symptom control, particularly in the early to mid-stages of the disorder. Pharmacological and non-pharmacological treatments are then urgently needed. During the last few decades, medical treatment for Parkinson’s disease (PD) has shown remarkable progress with the emergence of new drugs and technologies. For this Special Issue, we would like to invite authors to submit studies focusing on stem cell technology, gut microbiota and metabolites (such as short-chain fatty acids), immunotherapies, deep brain stimulation, gene therapies, and pharmacological management. Authors are welcome to cover other specific topics that have not been mentioned but fall within the theme of the Special Issue.
Prof. Dr. Dennis Qing Wang
Dr. Yinghua Yu
Prof. Dr. Deqin Geng
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- stem cell technology
- gut microbiota
- deep brain stimulation
- gene therapies
- phar-macological management